Acknowledgements The authors thank O. Dobler and I. Grigoriadou for excellent technical assistance. Funding Open Access funding enabled and organized by Projekt DEAL. Ethics declarations The authors declare no competing interests.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Igor Tsaur
Retroperitoneal Versus Transperitoneal Robot Assisted Partial Nephrectomy: A Prospective Controlled Non‐Randomized Single Centre Study Non‐Inferiority Design
1 Introduction Robot-assisted surgery for localised kidney cancer has become widely accepted in urological surgery. Since no real randomized controlled trial comparing robot versus open surgery has ever been conducted, the level of evidence for robot-assisted surgery does not exceed 2a [1]. In this way, in a current large and comprehensive meta-analysis, only two of 34 included studies were of prospective design [2].
Functional Recovery after the Application of Amniotic Tissues and Methylene Blue during Radical Prostatectomy-A Pilot Study
1. Introduction Nerve-sparing surgery has attracted much attention in recent years, especially in general surgical (e.g., rectal surgery), gynecologic (e.g., hysterectomy), and urologic operations. The functional outcome is an important quality-of-life parameter after radical prostatectomy (RP) for prostate cancer. There is an unmet need to improve continence and potency after pelvic surgeries such as radical prostatectomy.
A Systematic Review of the Emerging Role of Immune Checkpoint Inhibitors in Metastatic Castration-resistant Prostate Cancer: Will Combination Strategies Improve Efficacy?
Abstract Context The role of immune checkpoint inhibition (ICI) in the treatment of prostate cancer (PC) still remains elusive. It has been proposed that combination of ICI with other molecules increases the efficacy of immunotherapy in PC. Objective To systematically review the literature to assess the potential role of ICI in combination with additional therapies for the management of metastatic castration-resistant PC (mCRPC).
Hereditary prostate cancer - Primetime for genetic testing?
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Highlights •The proportion of all PCa attributable to high-risk hereditary factors is 5–15% •Germline mutations/alterations, single nucleotide polymorphisms or copy number variations are associated with PCa incidence and progression. •New technologies led to the evolvement of different commercially available tests for genetic testing.
Aggressive variants of prostate cancer - are we ready to apply specific treatment right now?
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Figure 1 Selected studies on systemic treatment of metastatic aggressive variants of prostate cancer.
Amygdalin Blocks Bladder Cancer Cell Growth In Vitro by Diminishing Cyclin A and cdk2
Amygdalin, a natural compound, has been used by many cancer patients as an alternative approach to treat their illness. However, whether or not this substance truly exerts an anti-tumor effect has never been settled. An in vitro study was initiated to investigate the influence of amygdalin (1.25–10 mg/ml) on the growth of a panel of bladder cancer cell lines (UMUC-3, RT112 and TCCSUP). Tumor growth, proliferation, clonal growth and cell cycle progression were investigated.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Igor
Contact Igor, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack